EyePoint Pharmaceuticals
EYPT
#10613
Rank
C$38.21 M
Marketcap
C$0.34
Share price
-11.36%
Change (1 day)
-98.26%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2026 (TTM): -C$0.43 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are C$2.78 Million. In 2025 the company made an earning of -C$0.34 Billion a decrease over its 2024 earnings that were of -C$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.43 Billion28.28%
2025 -C$0.34 Billion63.24%
2024 -C$0.21 Billion104.29%
2023 -C$99.62 Million-29.88%
2022 -C$0.15 Billion87.2%
2021 -C$75.9 Million38.58%
2020 -C$54.77 Million-24.56%
2019 -C$72.59 Million
2017 -C$33.11 Million22.59%
2016 -C$27.01 Million-8.02%
2015 -C$29.37 Million-296.09%
2014 C$14.97 M-174.02%
2013 -C$20.23 Million37.42%
2012 -C$14.72 Million-56.29%
2011 -C$33.68 Million-1062.38%
2010 C$3.49 M-250.43%
2009 -C$2.33 Million-89.5%
2008 -C$22.16 Million
2005 -C$13.67 Million56.99%
2004 -C$8.71 Million73.7%
2003 -C$5.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-C$3.1 Million-99.29% Bahamas
NRC Health
NRC
C$21.2 M-104.85%๐Ÿ‡บ๐Ÿ‡ธ USA